The Journal of International
Advanced Otology

Auditory Brainstem Implants in Children: Results Based on a Review of the Literature


Department of Otolaryngology, Sorocaba Eye Bank Hospital (BOS), Sorocaba, Brazil


Department of Otolaryngology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil; Department of Otolaryngology, Sorocaba Eye Bank Hospital (BOS), Sorocaba, Brazil

J Int Adv Otol 2014; 10: 284-290
DOI: 10.5152/iao.2014.135
Read: 1964 Downloads: 870 Published: 03 September 2019


The objective of this study is to review the literature regarding Auditory Brainstem Implant (ABI) indications, surgical techniques, activation methods, and post-surgery follow-up in children. A search was performed in the LILACS, MEDLINE, SciELO, and PubMed databases in June 2014, and the key words used in the search were ((“auditory brain stem implant” OR “auditory brainstem implants”) OR (“auditory” AND “brainstem” AND (“implants” OR “implant”)). Forty-two studies that met the criteria described in “Study Selection” were read in full; 24 studies referred to the ABI fitting process in children, and were selected for appraisal. The studies showed 120 children (younger than 18 years old) fitted with ABIs. Evaluation after surgery showed that 112 (93.3%) of the patients improved in their ability to recognize environmental sounds and speech perception. Patients with tumors or those with cochlear or cochlear nerve malformations had good outcomes as well. Two of the children did not achieve any sound perception upon ABI activation. The results obtained in 120 children fitted with an ABI showed that the patients globally improved in their ability to detect sounds and communication skills. The phenomenon could be seen both in patients with tumoral diseases of the inner ear and those with malformations of the cochlea or cochlear nerve, although patients with non-tumoral issues achieved better results than patients with schwannomas. We propose that the Food and Drug Administration (FDA) ABI indications should be extended to patients younger than 12 years old with NT diseases of the cochlea and cochlear nerve.

EISSN 2148-3817